Skip to content

ANAVEX LIFE SCIENCES CORP.

Public company
Headquarters
NEW YORK, New York
Industry
Biotechnology
Ticker
AVXL
CIK
0001314052

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

4
1 appointment, 3 departures

Last event

Nov 3, 2026
Executive appointmentCEO appointed: Terrie Kellmeyer, Ph.D.

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CEOTerrie Kellmeyer, Ph.D.Nov 3, 2026Appointed
Chair of the BoardJiong MaNov 2, 2026Departed
DirectorGautam PatelNov 2, 2026Departed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    CEO appointed: Terrie Kellmeyer, Ph.D.

    Terrie Kellmeyer, Ph.D. was named Chief Executive Officer (“CEO”) and President of ANAVEX LIFE SCIENCES CORP., effective November 1, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer (“CEO”) and President

    Source: SEC 8-K, filed Nov 3, 2026

  2. Executive departure

    Chair of the Board departs: Jiong Ma

    Jiong Ma, Chair of the Board of ANAVEX LIFE SCIENCES CORP., resigns the role, effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chair of the Board

    Source: SEC 8-K, filed Nov 2, 2026

  3. Executive departure

    Director departs: Gautam Patel

    Gautam Patel, Director of ANAVEX LIFE SCIENCES CORP., resigns the role, effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Nov 2, 2026

  4. Executive departure

    Director departs: Adrian Senderowicz

    Adrian Senderowicz, Director of ANAVEX LIFE SCIENCES CORP., resigns the role, effective October 28, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Director

    Source: SEC 8-K, filed Nov 2, 2026

Last verified Nov 8, 2026